iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Update

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the target of a significant increase in short interest in the month of December. As of December 15th, there was short interest totaling 4,328 shares, an increase of 205.9% from the November 30th total of 1,415 shares. Currently, 2.9% of the company’s stock are short sold. Based on an average daily volume of 1,514 shares, the days-to-cover ratio is presently 2.9 days. Based on an average daily volume of 1,514 shares, the days-to-cover ratio is presently 2.9 days. Currently, 2.9% of the company’s stock are short sold.

iShares Neuroscience and Healthcare ETF Stock Performance

IBRN stock opened at $32.51 on Friday. The firm has a 50 day moving average price of $30.63 and a 200-day moving average price of $26.63. iShares Neuroscience and Healthcare ETF has a 52-week low of $17.86 and a 52-week high of $33.32. The firm has a market capitalization of $4.88 million, a price-to-earnings ratio of 15.61 and a beta of 0.93.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.